Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Multiple Sclerosis Journal Année : 2024

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

1 UNISTRA - Université de Strasbourg
2 CRC-SEP Alsace - Centre de Ressources et de Compétences sur la Sclérose en Plaques (CRC-SEP) [Strasbourg]
3 OFSEP - Observatoire Français de la Sclérose En Plaques [Lyon]
4 CHU Nice - Centre Hospitalier Universitaire de Nice
5 CRMBM - Centre de résonance magnétique biologique et médicale
6 University Hospital of Montpellier
7 INM - Institut des Neurosciences de Montpellier
8 Fondation Ophtalmologique Adolphe de Rothschild [Paris]
9 CHU Rouen
10 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
11 Infinity - Institut Toulousain des Maladies Infectieuses et Inflammatoires
12 UNICAEN - Université de Caen Normandie
13 UCL - Université catholique de Lille
14 EHESP - École des Hautes Études en Santé Publique [EHESP]
15 UR - Université de Rennes
16 ARENES - Arènes: politique, santé publique, environnement, médias
17 RSMS - Recherche sur les services et le management en santé
18 CHU Pitié-Salpêtrière [AP-HP]
19 Service de neurologie [CHRU Nancy]
20 Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois]
21 IGF - Institut de Génomique Fonctionnelle
22 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
23 LilNCog - Lille Neurosciences & Cognition - U 1172
24 APHM - Assistance Publique - Hôpitaux de Marseille
25 NIMH - Neuropsychologie et imagerie de la mémoire humaine
26 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
27 Service de neurologie [Rouen]
28 AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
29 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
30 Centre Hospitalier Universitaire [Rennes]
31 EMPENN - Neuroimagerie: méthodes et applications
32 Centre Hospitalier de Gonesse
33 UCA - Université Clermont Auvergne
34 Neuro-Dol - Neuro-Dol
35 CHU de Bordeaux Pellegrin [Bordeaux]
36 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
37 Instit Cancéro - GARD - Institut de Cancérologie du GARD ICG - CHU Nîmes
38 Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL]
39 UniCA - Université Côte d'Azur
Bertrand Bourre
Gilles Defer
Elisabeth Maillart
Guillaume Mathey
Eric Thouvenot
Benjamin Hebant
Eric Manchon
  • Fonction : Auteur
  • PersonId : 1187453
Adil Maarouf
Alexis Montcuquet
Thomas Roux
Mikael Cohen

Résumé

Background: Epidemiological data reveal that 45% of persons with multiple sclerosis (PwMS) in France are more than 50 years. This population more than 50 is more susceptible to cancer, and this risk may be increased by frequent use of immunosuppressive drugs. Consequently, concerns have arisen about the potential increased risk of cancer in PwMS and how patients should be screened and managed in terms of cancer risk. Objective: To develop evidence-based recommendations to manage the coexistence of cancer and multiple sclerosis (MS). Methods: The French Group for Recommendations in MS collected articles from PubMed and university databases covering the period January 1975 through June 2022. The RAND/UCLA method was employed to achieve formal consensus. MS experts comprehensively reviewed the full-text articles and developed the initial recommendations. A group of multidisciplinary health care specialists then validated the final proposal. Results: Five key questions were addressed, encompassing various topics such as cancer screening before or after initiating a disease-modifying therapy (DMT), appropriate management of MS in the context of cancer, recommended follow-up for cancer in patients receiving a DMT, and the potential reintroduction of a DMT after initial cancer treatment. A strong consensus was reached for all 31 recommendations. Conclusion: These recommendations propose a strategic approach to managing cancer risk in PwMS.
Fichier non déposé

Dates et versions

hal-04479762 , version 1 (27-02-2024)

Licence

Paternité

Identifiants

Citer

Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frénay, Bertrand Audoin, Xavier Ayrignac, et al.. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society. Multiple Sclerosis Journal, 2024, Multiple Sclerosis Journal, ⟨10.1177/13524585231223880⟩. ⟨hal-04479762⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More